Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evogene (EVGN) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Evogene (EVGN) over the last 13 years, with Q3 2025 value amounting to -$10.3 million.

  • Evogene's Cash from Financing Activities fell 29211.9% to -$10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.6 million, marking a year-over-year decrease of 23896.08%. This contributed to the annual value of $4.7 million for FY2024, which is 7434.99% down from last year.
  • Latest data reveals that Evogene reported Cash from Financing Activities of -$10.3 million as of Q3 2025, which was down 29211.9% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, Evogene's Cash from Financing Activities registered a high of $27.5 million during Q1 2021, and its lowest value of -$10.3 million during Q3 2025.
  • For the 5-year period, Evogene's Cash from Financing Activities averaged around $2.5 million, with its median value being -$101500.0 (2021).
  • As far as peak fluctuations go, Evogene's Cash from Financing Activities surged by 137455000.0% in 2021, and later crashed by 79245.28% in 2024.
  • Evogene's Cash from Financing Activities (Quarter) stood at -$103000.0 in 2021, then plummeted by 245.63% to -$356000.0 in 2022, then surged by 58.71% to -$147000.0 in 2023, then tumbled by 40.14% to -$206000.0 in 2024, then plummeted by 4917.48% to -$10.3 million in 2025.
  • Its last three reported values are -$10.3 million in Q3 2025, $4.1 million for Q2 2025, and -$159000.0 during Q1 2025.